SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition
1Sidney Kimmel Cancer Center, San Diego, CA, USA.
Abstract:
Cell cycle controls ensure that DNA replication (S phase) follows mitosis resulting in two precise copies of the genome. A failure of the control mechanisms can result in multiple rounds of DNA replication without cell division. In endoreplication, cells with replicated genomes bypass mitosis, then replicate their DNA again, resulting in polyploidy. Endoreplication from G2 phase lacks all hallmarks of mitosis. Using synchronized cells, we show that the c-Jun N-terminal kinase (JNK) inhibitor, SP600125, prevents the entry of cells into mitosis and leads to endoreplication of DNA from G2 phase. We show that cells proceed from G2 phase to replicate their DNA in the absence of mitosis. This effect of SP600125 is independent of its suppression of JNK activity. Instead, the inhibitory effect of SP600125 on mitotic entry predominantly occurs upstream of Aurora A kinase and Polo-like kinase 1, resulting in a failure to remove the inhibitory phosphorylation of Cdk1. Importantly, our results directly show that the inhibition of Cdk1 activity and the persistence of Cdk2 activity in G2 cells induces endoreplication without mitosis. Furthermore, endoreplication from G2 phase is independent of p53 control.
Insights
A JNK inhibitor, SP600125, causes endoreplication by blocking mitotic entry. This occurs independently of JNK activity, highlighting a novel pathway for cell cycle control and polyploidy.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Cell cycle checkpoints ensure proper DNA replication and cell division.
- Failure in these controls can lead to endoreplication, where cells replicate DNA without dividing, resulting in polyploidy.
Purpose of the Study:
- To investigate the mechanism by which the JNK inhibitor SP600125 induces endoreplication from G2 phase.
- To elucidate the role of specific kinases and cell cycle regulators in this process.
Main Methods:
- Utilized synchronized cells to study the effects of SP600125.
- Investigated the impact of SP600125 on mitotic entry, kinase activity (JNK, Aurora A, PLK1), and Cdk1/Cdk2 phosphorylation.
- Assessed the role of p53 in SP600125-induced endoreplication.
Main Results:
- SP600125 inhibits mitotic entry and promotes G2 phase endoreplication, independent of JNK activity.
- The drug's effect on mitosis is upstream of Aurora A and Polo-like kinase 1, preventing inhibitory Cdk1 phosphorylation removal.
- Inhibition of Cdk1 and sustained Cdk2 activity in G2 cells drives endoreplication without mitosis.
- p53 is not required for SP600125-induced G2 endoreplication.
Conclusions:
- SP600125 induces endoreplication by disrupting mitotic entry through a pathway involving Cdk1 and Cdk2 regulation, independent of JNK.
- This study reveals a novel mechanism for inducing polyploidy and highlights potential targets for cell cycle control research.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
Positive Regulator Molecules
Positive Regulator Molecules


